Notification about latest news from us.
WuXi Biologics sells its Irish vaccine facility to Merck for $500 million as US restrictions on Chinese biotech loom.
UK approves Merck's sotatercept therapy, enhancing treatment for rare lung disease, following successful U.S. and EU approvals.
By clicking send you'll receive occasional emails from newsletters about this topic.